ALKEM — Alkem Laboratories Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Alkem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	12,598	18,421	18,443	13,048	20,231
Depreciation
Non-Cash Items	31.1	-1,099	-954	139	843
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-9,306	-7,418	-9,419	534	-4,586
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	5,851	12,649	11,110	16,825	19,481
Capital Expenditures	-3,631	-1,949	-3,389	-2,329	-2,593
Purchase of Fixed Assets
Other Investing Cash Flow Items	-3,783	-8,036	-10,963	3,458	-7,492
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,414	-9,985	-14,351	1,128	-10,085
Financing Cash Flow Items	-651	-536	-401	-905	-913
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	792	-2,718	3,796	-17,608	-11,450
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-731	-17.2	580	416	-2,075